CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

Novo Nordisk A/S soared the most since August 2023 after an experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.

Novo Nordisk A/S soared the most since August 2023 after an experimental shot delivered as much as 22% weight loss in an ...

Wegovy and Ozempic remain on the FDA's shortages ... the FDA to move semaglutide onto the 'Demonstrable Difficulties for Compounding' list of drugs that – while in limited supply – are ...

That means compounded versions of semaglutide – the active ingredient in Novo Nordisk's Ozempic and Rybelsus for diabetes and obesity therapy Wegovy – are already in the market. While Novo ...

On June 7, 2002, the FDA issued a compliance policy guidance to FDA staff and the drug compounding industry to explain how it will regulate pharmacy compounding in the immediate future in light of ...

The division of pharmacy at this institution provides sterile compounding training to employees, including a 20-hour didactic training course to all pharmacists and a 40- hour didactic course to ...